Global Cancer Immunotherapy Drug Discovery Outsourcing Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Type;
Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines and Others.Segmented by Servic;
Target Identification and Validation, Lead Screening and Characterization and Cell Bases Assays.Segmented by Cancer;
Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Cancer Immunotherapy Drug Discovery Outsourcing Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 66.5 |
2021 | 76.2 |
2022 | 84.1 |
2023 | 91.7 |
2024 | 94.8 |
2025 | 100.3 |
2026 | 112.9 |
2027 | 113.0 |
2028 | 117.6 |
2029 | 138.0 |
2030 | 145.9 |
In the year 2023, the Global Cancer Immunotherapy Drug Discovery Outsourcing Market was valued at USD 1,142.88 million. The size of this market is expected to increase to USD 2,688.73 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 13.0%.
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Cancer Immunotherapy Drug Discovery Outsourcing Market |
Study Period | 2020 - 2030 |
Base Year (for Cancer Immunotherapy Drug Discovery Outsourcing Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Cancer Immunotherapy Drug Discovery Outsourcing Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis
In this report, the Global Cancer Immunotherapy Drug Discovery Outsourcing Market has been segmented by Type, Servic, Cancer and Geography.
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation by Type
The Global Cancer Immunotherapy Drug Discovery Outsourcing Market has been segmented by Type into Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines and Others. The complete Global Cancer Immunotherapy Drug Discovery Outsourcing Market segmentation by Type can be seen below:
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Type
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies and Cancer Vaccines
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Types mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Type (USD Million), 2020 - 2030
# | Monoclonal Antibodies | Immunomodulators | Oncolytic Viral Therapies and Cancer Vaccines | Others |
---|---|---|---|---|
2020 | 80.6 | 68.0 | 74.9 | 106.1 |
2021 | 84.1 | 72.1 | 86.2 | 113.1 |
2022 | 85.7 | 73.3 | 87.7 | 127.0 |
2023 | 102.3 | 74.2 | 103.0 | 129.6 |
2024 | 116.4 | 80.8 | 106.1 | 141.5 |
2025 | 116.6 | 82.8 | 126.0 | 152.9 |
2026 | 128.7 | 98.1 | 134.1 | 173.4 |
2027 | 153.1 | 103.2 | 143.8 | 179.5 |
2028 | 165.3 | 122.9 | 154.5 | 202.6 |
2029 | 184.3 | 140.3 | 174.6 | 225.6 |
2030 | 217.7 | 147.1 | 201.7 | 260.8 |
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation by Servic
The Global Cancer Immunotherapy Drug Discovery Outsourcing Market has been segmented by Servic into Target Identification and Validation, Lead Screening and Characterization and Cell Bases Assays. The complete Global Cancer Immunotherapy Drug Discovery Outsourcing Market segmentation by Servic can be seen below:
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Servic
- Target Identification and Validation
- Lead Screening and Characterization
- Cell Bases Assays
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Servics mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Servic is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Servic (USD Million), 2020 - 2030
# | Target Identification and Validation | Lead Screening and Characterization | Cell Bases Assays |
---|---|---|---|
2020 | 67.2 | 100.9 | 80.8 |
2021 | 73.3 | 103.9 | 85.9 |
2022 | 87.6 | 111.1 | 101.4 |
2023 | 102.5 | 121.0 | 104.8 |
2024 | 108.3 | 132.8 | 106.4 |
2025 | 128.8 | 151.2 | 120.4 |
2026 | 153.3 | 161.2 | 143.0 |
2027 | 156.9 | 189.4 | 147.3 |
2028 | 156.9 | 193.8 | 150.1 |
2029 | 158.3 | 220.2 | 153.2 |
2030 | 164.2 | 227.4 | 162.4 |
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation by Cancer
The Global Cancer Immunotherapy Drug Discovery Outsourcing Market has been segmented by Cancer into Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer. The complete Global Cancer Immunotherapy Drug Discovery Outsourcing Market segmentation by Cancer can be seen below:
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head and Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Cancers mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Cancer is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Cancer (USD Million), 2020 - 2030
# | Lung Cancer | Breast Cancer | Colorectal Cancer | Melanoma | Prostate Cancer | Head and Neck Cancer | Ovarian Cancer | Pancreatic Cancer |
---|---|---|---|---|---|---|---|---|
2020 | 103.4 | 109.5 | 82.9 | 71.4 | 83.8 | 115.3 | 101.4 | 85.4 |
2021 | 109.3 | 114.7 | 89.7 | 77.8 | 92.0 | 120.0 | 114.8 | 95.4 |
2022 | 126.4 | 127.3 | 102.6 | 82.2 | 100.3 | 137.3 | 130.5 | 109.4 |
2023 | 150.2 | 133.2 | 112.0 | 91.6 | 117.1 | 154.6 | 155.1 | 119.7 |
2024 | 156.0 | 145.9 | 114.5 | 97.0 | 139.8 | 180.2 | 185.7 | 131.2 |
2025 | 157.8 | 148.2 | 134.6 | 104.2 | 149.0 | 186.1 | 219.2 | 143.3 |
2026 | 168.5 | 168.6 | 136.3 | 117.1 | 155.6 | 192.7 | 241.3 | 149.2 |
2027 | 177.1 | 178.5 | 153.0 | 125.9 | 186.1 | 201.6 | 252.4 | 156.7 |
2028 | 182.3 | 194.8 | 181.8 | 139.0 | 217.3 | 235.9 | 272.8 | 179.4 |
2029 | 206.6 | 226.6 | 195.3 | 162.7 | 239.3 | 274.2 | 295.2 | 194.0 |
2030 | 245.0 | 265.0 | 212.6 | 194.9 | 283.9 | 285.8 | 317.3 | 228.2 |
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation by Geography
In this report, the Global Cancer Immunotherapy Drug Discovery Outsourcing Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Cancer Immunotherapy Drug Discovery Outsourcing Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Cancer Immunotherapy Drug Discovery Outsourcing in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Cancer Immunotherapy Drug Discovery Outsourcing Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The factors driving the growth of Global Cancer Immunotherapy Drug Discovery Outsourcing Market will be discussed in detail in the full report.
- While the growth of Global Cancer Immunotherapy Drug Discovery Outsourcing Market is currently hindered by; Quality issues involved with drug discovery CRO services and Intellectual property right issues.
- The new opportunities in Global Cancer Immunotherapy Drug Discovery Outsourcing Market will be discussed in detail in the full report.
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers will be discussed in detail in the full report.
- Quality issues involved with drug discovery CRO services.
- Intellectual property right issues.
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Cancer Immunotherapy Drug Discovery Outsourcing Market. The opportunity map (by market segments; Type, Servic and Cancer) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Cancer Immunotherapy Drug Discovery Outsourcing Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Cancer Immunotherapy Drug Discovery Outsourcing Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Cancer Immunotherapy Drug Discovery Outsourcing Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Cancer Immunotherapy Drug Discovery Outsourcing Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Cancer Immunotherapy Drug Discovery Outsourcing Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Cancer Immunotherapy Drug Discovery Outsourcing Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Cancer Immunotherapy Drug Discovery Outsourcing Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Cancer Immunotherapy Drug Discovery Outsourcing Market include, Explicit Immuno-Oncology, Aquila Biomedical, Horizon Discovery Group plc, Crown Bioscience Inc., Promega Corporation, HD Biosciences Co. Ltd., BPS Biosciences Inc. and Gen script Biotech Corporation.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Servic
- Market Snapshot, By Cancer
- Market Snapshot, By Region
- Market Opportunity Map
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Quality issues involved with drug discovery CRO services
- Intellectual property right issues
- Opportunities
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Type, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Immunomodulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Oncolytic Viral Therapies and Cancer Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Monoclonal Antibodies
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Servic, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Target Identification and Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Lead Screening and Characterization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Cell Bases Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Target Identification and Validation
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Head and Neck Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Ovarian Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pancreatic Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Lung Cancer
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Servic, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Type, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Explicit Immuno-Oncology
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Aquila Biomedical
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Horizon Discovery Group plc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Crown Bioscience Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Promega Corporation
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- HD Biosciences Co. Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- BPS Biosciences Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Gen script Biotech Corporation
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Explicit Immuno-Oncology
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Cannabis Cultivation Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Cannabis Extract Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Cannabis Pharmaceuticals Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Cardiac Catheters & Guidewires Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%